Skip to content
⤶
Skip to footer
⤶
Home
Events
Join us
Contact
Staff
Search
About
Our Story
Our Mission
The Team
Clinical Support
Immunotherapy Toxicity Guidelines
Patient Information
Consent Forms
Case Studies
Specialist Support
Multi-Disciplinary Team
Video Resources for Patients
ICI Cardiovascular Complications Guidance
Education
Our Education Ethos
The Immunobuddies Podcast
Events
'Ask a Question' Webinar Series
New & Novel Webinar Series
The National IO Education Forum
Policy & Governance
Organisations we work with
Pharmacovigilence
IOCN Policies & Constitution
Research
Service Development
Share: twitter
Share: facebook
Share: linkedin
Currently viewing:
Home
Clinical Support
Consent Forms
Consent Forms
Cancer Research UK (CRUK) Consent forms for Systemic Anti-Cancer Treatment (SACT)
Immunotherapy regimens
Atezolizumab
Avelumab
Durvalumab
Ipilimumab
Ipilimumab and Nivolumab
Nivolumab
Pembrolizumab
Immunotherapy combination treatment:
Atezolizumab, Bevacizumab, Caroplatin and Paclitaxel
Atezolizumab, Caroplatin and Etoposide
Avelumab and Axitinib
Carboplatin, Paclitaxel and Pembrolizumab
Carboplatin, Pemetrexed and Pembrolizumab
Cisplatin, Pemetrexed and Pembrolizumab
